Stock Price Quote

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE634.40-21.65 (-3.3 %)
PREV CLOSE ( ) 656.05
OPEN PRICE ( ) 656.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1121
TODAY'S LOW / HIGH ( )625.00 656.65
52 WK LOW / HIGH ( )591.1 861.4
NSE631.90-24.25 (-3.7 %)
PREV CLOSE( ) 656.15
OPEN PRICE ( ) 661.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 631.90 (49)
VOLUME 12310
TODAY'S LOW / HIGH( ) 625.00 661.25
52 WK LOW / HIGH ( )596 862.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-09 1936
Management Info
S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director
Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044-24994164 / 24994146 / 24994465 / 24994366

Email shares@amrutanjan.com

Website www.amrutanjan.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE

NEWS

17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..
08Jul Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..
25Jun Amrutanjan Health Care informs about t
Amrutanjan Health Care has informed that the trading window for dealing..
13Jun Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that the exchange has received the d..
10Jun Amrutanjan Health Care informs about a
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Re..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit117.96449.72
Gross Profit 159.41 619.45
Operating Profit 176.49681.59
Net Sales 1099.154212.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  5949.15 (0.31%)
M.Cap ( in Cr)157931.24
Everest Organics (BSE)
peergroup  270.00 (1.96%)
M.Cap ( in Cr)262.18
Shukra Pharma (BSE)
peergroup  219.50 (1.95%)
M.Cap ( in Cr)961.15
Panchsheel Organics (BSE)
peergroup  198.75 (1.71%)
M.Cap ( in Cr)261.79
Medico Remedies (BSE)
peergroup  69.97 (2.09%)
M.Cap ( in Cr)580.64

Shareholding Pattern

MUTUAL FUNDS/UTI 9.21%
PROMOTERS 46.52%
NON-INSTITUTION 40.06%
FI/BANKS/INSURANCE 0.09%
GOVERNMENT 0%
FII 0%

About Amrutanjan Health Care Ltd.

Amrutanjan Health Care Ltd. was incorporated in the year 1936. Its today's share price is 634.4. Its current market capitalisation stands at Rs 1834.09 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4212.31 Cr and Total Income of Rs.4375.79 Cr. The company's management includes Nagaraj Viswanathan, Ramaa Prabhakar Arikirevula, G Raghavan, Meenalochani Raghunathan, S Muralidharan, Raja Venkataraman, S Sambhu Prasad, S Sambhu Prasad, M Srinivasan.

It is listed on the BSE with a BSE Code of 590006 , NSE with an NSE Symbol of AMRUTANJAN and ISIN of INE098F01031. It's Registered office is at New 103 (Old 42-45),Luz Church Road,MylaporeChennai-600004, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, PS Subramania Iyer & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.